Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Study completedNCT03370276What this trial is testingCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more H. Lee Moffitt Cancer Center and Research Institute 95
Testing effectiveness (Phase 2)Ended earlyNCT02196168What this trial is testingCisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Ended earlyNCT00720083What this trial is testingChemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 34
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Large-scale testing (Phase 3)Active Not RecruitingNCT03340896What this trial is testingTrial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RTWho this might be right forHead and Neck Squamous Cell Carcinoma Groupe Oncologie Radiotherapie Tete et Cou 256
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableUnknownNCT00415298What this trial is testingAP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer University of California, San Diego 12
Large-scale testing (Phase 3)Study completedNCT00004234What this trial is testingOral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck CancerOral Complications NCIC Clinical Trials Group
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Ended earlyNCT01066741What this trial is testingPrevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum CancerWho this might be right forOropharynx CancerHypopharynx Cancer Centre Leon Berard 78
Testing effectiveness (Phase 2)Study completedNCT03342911What this trial is testingNivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by SurgeryWho this might be right forName Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma+19 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Large-scale testing (Phase 3)Looking for participantsNCT06706401What this trial is testingLymphocyte-Sparing And Radio-Immunotherapy in Head and Neck CarcinomaWho this might be right forOropharynx CancerLarynx CancerHypopharynx Cancer+1 more Centre Leon Berard 460
Testing effectiveness (Phase 2)UnknownNCT05420597What this trial is testingInduction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal CarcinomaWho this might be right forLaryngeal CancerHypopharyngeal Cancer Fudan University 61
Early research (Phase 1)Study completedNCT00470496What this trial is testingPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT06831149What this trial is testingUse of SPY Imaging System to Minimize Fistulas After Hypopharyngeal ReconstructionWho this might be right forSquamous Cell CarcinomaPharyngocutaneous Fistula Matthew Spector 225
Testing effectiveness (Phase 2)WithdrawnNCT00095641What this trial is testingS0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT01208883What this trial is testingA Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck CancerWho this might be right forSquamous Cell Carcinoma University Hospital, Ghent 10
Early research (Phase 1)Study completedNCT02775812What this trial is testingCisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell CarcinomaWho this might be right forStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more National Cancer Institute (NCI) 37